{
    "clinical_study": {
        "@rank": "115870", 
        "arm_group": [
            {
                "arm_group_label": "Control Supplement", 
                "arm_group_type": "Placebo Comparator", 
                "description": "soft-gel placebo capsules, 2 capsules from the placebo bottle per day"
            }, 
            {
                "arm_group_label": "Experimental Supplement A", 
                "arm_group_type": "Experimental", 
                "description": "soft-gel capsules; 1 capsule from the experimental bottle and 1 capsule from the placebo bottle per day"
            }, 
            {
                "arm_group_label": "Experimental Supplement B", 
                "arm_group_type": "Experimental", 
                "description": "soft-gel capsules; 2 capsules from the experimental bottle per day"
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate the impact of nutrient supplementation during lactation on levels in breast\n      milk."
        }, 
        "brief_title": "Lactation Fortification Study", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Lactation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Subjects will be eligible for the study if they meet all of the following inclusion\n        criteria:\n\n          1. Mother with singleton birth, 37-42 weeks gestation and \u2265 2490g\n\n          2. Pre-pregnancy BMI </= 30\n\n          3. Mother is \u2265 18 years of age\n\n          4. Mother is 4-6 weeks postpartum and has been successfully continuously lactating\n\n          5. Mother agrees to abstain from the use of any Docosahexaenoic acid (DHA), lutein\n             and/or vitamin E containing supplements for at least 10 days prior to providing a\n             baseline breast milk sample\n\n          6. Mother agrees to abstain from the use of non-study supplements throughout the study\n\n          7. Mother plans to continue breastfeeding for at least 6 weeks from the start of the\n             study\n\n          8. No significant ongoing medical problems in the infant as determined from infant's\n             medical history as related by the parent(s) to the enrolling center personnel\n\n        Exclusion Criteria:\n\n        Subjects will be excluded from the study if they meet any of the following criteria:\n\n          1. Subject had adverse maternal and/or fetal medical history\n\n          2. Subject is participating in a non-Abbott approved concomitant trial\n\n          3. Mother is taking cholesterol medication and/or medication affecting lipid absorption\n             and/or transport"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "89", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01747668", 
            "org_study_id": "AL05"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Experimental Supplement A", 
                    "Experimental Supplement B"
                ], 
                "description": "One capsule per day for Experimental Supplement A Group; Two capsules per day for Experimental Supplement B Group", 
                "intervention_name": "Similac Prenatal Vitamin soft-gel capsule", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Control Supplement", 
                    "Experimental Supplement A"
                ], 
                "description": "Two capsules per day for the Placebo Group; One capsule per day for the Experimental Group A", 
                "intervention_name": "Placebo (soybean oil and dl-alpha-tocopheryl acetate)", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Mother and Infant Pairs", 
        "lastchanged_date": "May 30, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46256"
                    }, 
                    "name": "Northpoint Pediatrics, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45414"
                    }, 
                    "name": "Ohio Pediatric Research Association, Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kettering", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45420"
                    }, 
                    "name": "Ohio Pediatric Research Association, Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mayfield Heights", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44124"
                    }, 
                    "name": "Institute of Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parma", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44129"
                    }, 
                    "name": "The Cleveland Pediatric Research Center, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westlake", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44145"
                    }, 
                    "name": "The Cleveland Pediatric Research Center, LLC"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Impact of Nutrient Supplementation on Breast Milk Levels of Lactating Women", 
        "other_outcome": {
            "description": "In mothers at 1 and 43 days In infants at 43 days", 
            "measure": "Blood levels of nutrients and fatty acids", 
            "safety_issue": "No", 
            "time_frame": "1 and 43 days"
        }, 
        "overall_official": {
            "affiliation": "Abbott Nutrition", 
            "last_name": "Christina Sherry, PhD, RD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Breast milk concentration of carotenoids", 
            "safety_issue": "No", 
            "time_frame": "1 - 43 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01747668"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Breast milk concentration of fatty acids", 
            "safety_issue": "No", 
            "time_frame": "1 - 43 days"
        }, 
        "source": "Abbott Nutrition", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Nutrition", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}